Parkinson’s Disease and Fabry Disease: Clinical, Biochemical and Neuroimaging Analysis of Three Pedigrees

BACKGROUND: Sporadic Parkinson’s disease (PD) patients have lower α-galactosidase A (α-GAL A) enzymatic activity and Fabry disease (FD) patients potentially carry an increased risk of PD. OBJECTIVE: Determination of PD prevalence in FD and clinical, biochemical and vascular neuroimaging description...

Descripción completa

Detalles Bibliográficos
Autores principales: Gago, Miguel Fernandes, Azevedo, Olga, Guimarães, Andreia, Teresa Vide, Ana, Lamas, Nuno J., Oliveira, Tiago Gil, Gaspar, Paulo, Bicho, Estela, Miltenberger-Miltenyi, Gabriel, Ferreira, Joaquim, Sousa, Nuno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029331/
https://www.ncbi.nlm.nih.gov/pubmed/31594250
http://dx.doi.org/10.3233/JPD-191704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029331/
https://www.ncbi.nlm.nih.gov/pubmed/31594250
http://dx.doi.org/10.3233/JPD-191704

Ejemplares similares